Prostamax 20mg

Researchers evaluating where to buy Prostamax for research should begin with compound identity, batch documentation, and RUO labeling rather than consumer-facing claims. Prostamax is cataloged as the KEDP tetrapeptide, with the sequence H-Lys-Glu-Asp-Pro-OH and molecular formula C20H33N5O9 in PubChem [1]. Review its laboratory documentation, COA, analytical testing, and published research as separate evidence categories.

• Prostamax is a short peptide research material associated with the KEDP sequence in compound databases [1].
• Published Prostamax research includes chromatin and heterochromatin model literature, including lymphocyte chromatin work [2].
• Bioregulator peptide research provides literature context, not evidence of performance for a supplied laboratory material.
• Research buyers should review COA data, peptide identity, purity testing, lot traceability, label consistency, and storage documentation.
• HPLC can support peptide purity review, while LC-MS can support identity and impurity characterization when properly documented [16] [17].
• Products discussed in this article are intended strictly for laboratory research use and are not intended for human or animal consumption.

Fast Answer: What Should Researchers Check Before They Buy Prostamax for Research?

Researchers evaluating where to buy Prostamax for research should first check the compound identity, batch-specific COA, analytical testing method, lot number, label consistency, and RUO documentation. Products discussed in this article are intended for laboratory research use only and are not intended for human or animal consumption. Scientific literature should be treated as background context, not product-use guidance.

What Documentation Should Come First?

The first documents to review are the product listing, batch-specific certificate of analysis, analytical method summary, and lot-level records. A COA should connect to a specific batch and should not be treated as a generic marketing asset.

For reference materials, NIST describes certified reference material documentation as including certified values, uncertainty, and traceability statements [28]. Research peptide COA review should use the same general discipline: identify what was tested, by whom, when, and for which lot.

Why Does RUO Labeling Matter Before Procurement?

RUO labeling matters because it defines the intended research context for the material. FDA guidance for research-use-only IVD products emphasizes that RUO labeling must be consistent with the intended research context and not represented for diagnostic purposes [22].

Research-Use-Only Context for Prostamax Peptide

Evaluate Prostamax through compound identity, documentation quality, and the limits of published research.

This material is intended for laboratory research only, not wellness, clinical, or consumer use.

What Does Research-Use-Only Mean?

Research-only labeling does not establish suitability for other uses. FDA’s in vitro diagnostic labeling regulation includes language for products in the laboratory research phase, including the statement “For Research Use Only. Not for use in diagnostic procedures” [23].

Prostamax Peptide Description in Research Literature

Prostamax is a synthetic tetrapeptide research compound associated with the KEDP sequence. PubChem lists Prostamax as H-Lys-Glu-Asp-Pro-OH, sequence KEDP, molecular formula C20H33N5O9, and molecular weight 487.51 g/mol [1].

Compound Identity and Research Classification

Prostamax is a short peptide with four amino acid residues in KEDP order: lysine, glutamic acid, aspartic acid, and proline [1]. Short peptide literature discusses peptide-DNA interactions, chromatin context, and gene-expression models [5].

Why Does Peptide Sequence Matter for Documentation?

Peptide sequence matters because identity review depends on matching the named compound to its expected amino acid order. PubChem provides the KEDP sequence for Prostamax [1].

Sequence review also helps researchers compare product-page information against COA data, LC-MS output, and supplier documentation. If the sequence, name, and mass information do not align, procurement review should pause.

What Makes a Synthetic Tetrapeptide Description Useful?

A synthetic tetrapeptide description is useful when it is precise, documentable, and testable. General peptide synthesis literature describes solid-phase peptide synthesis as a standard method family for constructing peptides [26].

Scientific Background for Bioregulator Peptide Research

Bioregulator peptide research often examines short peptides in molecular, cellular, DNA, chromatin, and gene-expression contexts. A systematic review by Khavinson and colleagues discusses short peptides, DNA interactions, histone-related mechanisms, gene expression, and protein synthesis as research themes [5].

That literature provides background for interpreting Prostamax research; it does not establish outcomes for the supplied product.

Short Peptide Research and Prostate Tissue Context

The prostate is a gland in the male reproductive system, and NCI describes it as surrounding part of the urethra below the bladder [11]. Anatomy literature describes prostate tissue as organized into epithelial and stromal compartments, which are relevant to cell and tissue research models [12].

Prostate tissue research provides anatomical and model-specific context, not evidence of health outcomes for a supplied Prostamax product.

What Role Does Cellular Model Selection Play?

Cellular model selection shapes what a study can and cannot show. Prostate epithelial-stromal co-culture research illustrates how model design can influence tissue-context interpretation [13].

In vitro findings, preclinical literature, and analytical documentation are not interchangeable.

Chromatin and Cellular Model Literature Context

Chromatin is the DNA-protein structure that packages genetic material in eukaryotic cells. NCBI Bookshelf describes heterochromatin as a highly condensed chromatin state that is generally transcriptionally inactive [9].

This background helps explain why Prostamax literature often uses chromatin and heterochromatin terminology.

How Does Chromatin Structure Appear in Published Research?

Chromatin structure appears in the literature as a way to study DNA accessibility, gene regulation, and nuclear organization. Review literature describes chromatin compaction as relevant to transcription, replication, and DNA repair processes [10].

One Prostamax paper examined the peptide bioregulator Prostamax on heterochromatin of lymphocytes in situ and reported thermal changes interpreted as small structural changes in chromatin [2].

Heterochromatin Notes for Laboratory Interpretation

Heterochromatin is an architectural feature of eukaryotic chromosomes with specific functional roles in genome organization [8].

A second KEDP-related paper discussed chromatin deheterochromatinization in an age-related research context and reported changes in chromosomal parameters, including sister chromatid exchanges [3]. That evidence remains model-specific.

Lymphocyte Chromatin Models

Lymphocyte chromatin literature can be relevant to peptide bioregulator research because it provides a cellular model for chromatin state observations. Khavinson, Lezhava, and Malinin examined short peptides on lymphocyte chromatin in senile subjects in a published study [4].

Published Literature Context for Prostamax Research

Published Prostamax research is narrow compared with broader peptide literature. The most relevant sources are compound identity records, chromatin model studies, short peptide reviews, and analytical chemistry guidance.

Some published literature outside the scope of RUO product use has examined this compound class in human study settings. That literature should not be interpreted as a use claim for research-use-only materials.

How Does Source Quality Shape Literature Interpretation?

Source quality determines how much weight a research buyer should place on a claim. Peer-reviewed literature, official databases, and official standards should rank above marketing pages, forums, and unsourced summaries.

For Prostamax, PubChem supports compound identity [1]. PubMed-indexed Prostamax literature supports chromatin-context review [2] [3]. Analytical standards and method-validation guidance support documentation review [14].

What Can Published Data Support or Not Support?

Published data can support careful statements about what a study examined. It cannot support claims about Pure Lab Peptides materials unless the exact product lot was tested in the relevant study.

Published work includes a Prostamax chromatin-model report [2] and a KEDP age-related chromatin-model report [3]. Their findings do not establish performance of a supplied product.

Evidence Interpretation Framework for Research Buyers

Research buyers need a way to sort literature without overstating it. A simple evidence ladder helps: official database identity, analytical testing, model-specific literature, broader peptide reviews, and RUO boundary review.

Evidence Ladder for Preclinical and In Vitro Context

An evidence ladder helps prevent overstatement. In vitro research can describe model observations; model-based literature can describe experimental endpoints; official databases can describe identity; analytical records can describe a batch.

Short peptide modeling literature proposes DNA-peptide interaction frameworks for multiple short peptides [6].

Limits of Literature Findings

Literature findings do not establish that a supplied product will reproduce a study outcome.

Research Literature and Product Claim Separation

Literature describes what a study examined. A product listing alone does not establish that the supplied material reproduces the same result.

Why Does Labeling Consistency Matter?

FDA RUO guidance emphasizes intended-use consistency in labeling and distribution context [22].

COA Documentation and Review Workflow for Prostamax Peptide

A COA is most useful when it is batch-specific, method-aware, and connected to the exact product listing. Certificates of analysis should not be treated as interchangeable across lots.

NIST describes reference materials as coming with documentation that states certified or reference values and related information [20]. That principle supports COA discipline for research materials.

What Should Certificates of Analysis Show?

A Prostamax COA should show the compound name, lot number, test date, testing method, purity result, identity support, and laboratory source. Where applicable, it should also show chromatographic or mass data.

A COA does not replace full analytical review. It is one document in a larger supplier documentation set.

How Should COA Dates and Lot Numbers Align?

COA dates and lot numbers should align with the product record being evaluated. If a COA points to a different lot, it should not be assumed to represent the listed material.

Batch matching is a documentation issue. It is not a scientific claim, but it is essential for technical procurement.

Why Do Third-Party Testing Records Matter?

Third-party testing records can add confidence when the testing source, method, and lot connection are clear. ISO/IEC 17025 is a recognized framework for laboratory competence and valid results [21].

That does not mean every COA is equivalent. Research buyers should look for method details, identity support, and traceability.

HPLC and LC-MS Analytical Verification

HPLC and LC-MS serve different roles in peptide documentation. HPLC is commonly used to evaluate peptide purity and separation profiles, while LC-MS can support identity and impurity characterization [16] [17].

For research procurement, the practical question is whether the analytical method matches the claim being made. Purity and identity are related, but not identical.

How Does HPLC Support Peptide Purity Review?

HPLC supports peptide purity review by separating peptide-related components and producing chromatographic data that can be interpreted for purity assessment [16]. The chromatogram should connect to the relevant lot.

A purity percentage should be read with method context. Researchers should ask what method was used, what wavelength or detection system was applied, and whether the COA ties to the listed batch.

How Does LC-MS Support Prostamax Identity Review?

LC-MS supports identity review by connecting chromatographic separation with mass information. Synthetic peptide characterization literature describes LC-MS workflows for identifying impurities and confirming structural features in peptide analysis [17].

Peptide mapping literature also shows how LC-MS can connect mass data and sequence-related confirmation in analytical workflows [18]. For Prostamax, LC-MS documentation should align with KEDP identity information from PubChem [1].

Lab-Test Verification Protocol

1. Verify that the compound name, lot number, and label match across the product page, COA, and supplier documentation.
2. Review the batch-specific COA before relying on purity or identity statements.
3. Check whether the purity testing method is listed; HPLC is a common peptide purity method [16].
4. Confirm whether identity testing is supported by LC-MS, mass spectrometry, or another suitable analytical method [17].
5. Review chromatogram or mass data when available, including retention-time and mass-to-charge information.
6. Check the COA date, laboratory source, and batch connection.
7. Document storage and handling requirements in the laboratory record.

Lot Traceability and Batch-Specific Records

Lot traceability links the product listing to the physical batch, COA, analytical record, and storage documentation. Without that link, product-page claims become difficult to audit.

A strong documentation set should allow a research team to follow the record from listing to batch to testing.

What Should Each Batch Record Connect?

Each batch record should connect the compound name, lot number, COA, analytical method, test date, and storage notation. If any of these pieces are missing, the documentation review is incomplete.

Batch-specific documentation matters because peptide materials can vary by lot, test method, and storage history.

Label Consistency Across Research Documentation

Label consistency means the same compound name, sequence, catalog amount, lot number, and RUO statement appear across documents. A listing such as Prostamax 20mg should be read as a catalog specification only.

The label should also avoid claims that conflict with the RUO frame.

Supplier Documentation Review for Lab Peptides

Researchers are not just comparing lab peptides by name; they are comparing the strength of the supporting record.

A useful supplier record should include product identity, COA availability, analytical data, lot traceability, storage notes, and RUO labeling.

What Should Research Buyers Compare Across Suppliers?

Research buyers should compare COA availability, batch-level testing, analytical method clarity, label consistency, and documentation completeness. Supplier comparison should not rely on marketing language.

A source-quality filter helps: official database first, peer-reviewed literature second, analytical records third, marketing language last.

How Do Quality Standards Support Procurement Review?

Quality standards support procurement review by giving teams a common vocabulary for laboratory competence, method validation, and documentation control. ICH Q2(R2) describes analytical procedure validation concepts such as suitability for intended analytical purpose [14].

FDA analytical-method guidance also discusses validation characteristics and method suitability for analytical procedures [15]. These sources are not product endorsements; they are documentation benchmarks.

Storage and Handling Documentation for Lyophilized Peptide

Lyophilized peptide documentation should describe storage expectations in research-record terms. Storage conditions affect whether the material’s analytical record remains meaningful over time.

Peptide storage literature shows that peptide stability can vary by storage condition and peptide properties [24]. Documentation should therefore be specific rather than generic.

Why Do Lyophilized Materials Need Storage Notes?

Lyophilized materials need storage notes because moisture, temperature, and handling history can affect peptide stability. Recommendations for peptide reference materials in quantitative workflows emphasize storage, stability, and documentation as part of analytical reliability [25].

How Should Storage Conditions Be Documented?

Storage conditions should be documented as part of the laboratory record: date received, lot number, storage temperature, and any supplier storage notation. These details help preserve traceability.

The storage note should match the product label and COA when applicable. If the label and documentation disagree, the discrepancy should be resolved before research planning.

Common Misunderstandings in Research Procurement

Several misunderstandings can weaken RUO product-page interpretation. The most common issue is treating literature as if it describes a product claim.

A second misunderstanding is treating a single purity percentage as complete identity confirmation. A third is treating catalog size as research interpretation.

Misinterpretation of COA Results

A COA can support documentation review, but it does not prove every analytical question. HPLC purity data and LC-MS identity data answer different questions [16] [17].

A strong review asks whether the COA is batch-specific, whether the method is named, and whether identity evidence aligns with the expected compound.

Model-Specific Research Terms

Condition-specific findings and histology observations, such as infiltration, require interpretation within the model and study conditions. They do not establish prostate-health outcomes for an RUO product.

Separating Literature, Batch Data, and Supplier Claims

Compare three distinct sources: what the literature examined, what the COA documents, and what the supplier claims. One cannot substitute for another.

Final Research Procurement Review for Prostamax

The final review should ask one question: does the documentation support the research material listing? If the answer is unclear, the procurement record is not complete.

A research procurement record includes identity, purity, lot traceability, analytical testing, label consistency, storage documentation, and the research-only designation.

Buy Prostamax for Research: Documentation Checklist

• Verify that Prostamax is labeled for research-use-only context.
• Review the batch-specific COA before relying on purity or identity claims.
• Confirm that the expected KEDP identity aligns with PubChem compound data [1].
• Check whether HPLC or another suitable method supports peptide purity review [16].
• Confirm whether LC-MS or mass spectrometry supports identity review [17].
• Match the lot number across the product listing, label, COA, and supplier documentation.
• Compare storage notes across the product page and laboratory record.
• Document the final procurement review in a laboratory record.

Next Steps for Research Teams

Review the product-page documentation, COA details, analytical testing information, lot traceability, and RUO labeling before evaluating Prostamax for laboratory research. For research teams comparing peptide suppliers, prioritize transparent documentation over marketing language.

FAQs

What does research use only mean for Prostamax?

Research use only means Prostamax is intended solely for laboratory research contexts. Products are for research use only and are not intended for human or animal consumption.

What should researchers consider before they buy Prostamax for research?

Researchers should review the product listing, COA, lot traceability, peptide identity, storage documentation, and analytical testing records before buying Prostamax for research. Catalog details describe the listing; they do not provide use instructions or establish outcomes.

Why does a COA matter when evaluating Prostamax?

A COA matters because it helps connect Prostamax documentation to a specific lot, test date, purity review, and identity record. Research buyers should review whether the COA aligns with the product label and batch-specific documentation. A COA is strongest when paired with clear supplier documentation and method details.

How should published literature about Prostamax be interpreted?

Published Prostamax literature provides research context, not product-use guidance. Studies of peptide bioregulation, tissue-specific models, or chromatin-related research remain specific to their experimental conditions and do not establish outcomes for a supplied research material.

What Do Chromatin Models Show in Prostamax Research?

Chromatin models help researchers examine DNA accessibility, nuclear organization, and related cellular observations. Those findings remain specific to the experimental model, not the supplied product.

What documentation supports Prostamax product-page evaluation?

Evaluate a Prostamax listing through RUO labeling, COA availability, compound characterization, lot traceability, storage documentation, and testing records. Cell-culture findings and other model references provide research context; analytical documentation separately describes the supplied batch.

---

Researchers Cited in This Guide

The researchers listed below are cited for relevant published work. Their inclusion does not imply that they wrote, reviewed, or endorsed this guide or Pure Lab Peptides products.

Vladimir Khavinson

Author profile: PubMed Author Search

Vladimir Khavinson’s publications cover short peptides, peptide bioregulation, chromatin, and gene-expression models. The selected publications provide background for interpreting Prostamax within this broader molecular research literature.

Selected publications:

• Peptide Regulation of Gene Expression: A Systematic Review — Molecules, 2021. DOI: 10.3390/molecules26227053
• Short Peptides Regulate Gene Expression — Bulletin of Experimental Biology and Medicine, 2016. PMID: [27909961]

Teimuraz Lezhava

Author profile: PubMed Author Search

Teimuraz Lezhava’s coauthored publications address Prostamax, heterochromatin, lymphocyte chromatin, and short-peptide research models. These studies provide model-specific background for interpreting the published findings.

Selected publications:

• A Prostamax heterochromatin model study — Biofizika, 2004. PMID: [15612551]
• A study on short peptides and lymphocyte chromatin models — Bulletin of Experimental Biology and Medicine, 2004. DOI: 10.1023/B:BEBM.0000024393.40560.05

REFERENCES

1. National Center for Biotechnology Information. Prostamax compound record. PubChem. Accessed 2026.
2. Meskhi T, Khachidze D, Barbakadze Sh, Madzhagaladze G, Gorgoshidze M, Monaselidze D, Lezhava T, Tadumadze N. Prostamax and lymphocyte heterochromatin research record. Biofizika. 2004. PMID: 15612551.
3. Dzhokhadze TA, Buadze TZh, Gaĭozishvili MN, Baratashvili NA, Lezhava TA. KEDP and age-related chromatin research record. Georgian Medical News. 2012. PMID: 23221144.
4. Khavinson VK, Lezhava TA, Malinin VV. Short peptides and lymphocyte chromatin research. Bulletin of Experimental Biology and Medicine. 2004. DOI: 10.1023/B:BEBM.0000024393.40560.05.
5. Khavinson VK, Popovich IG, Linkova NS, Mironova ES, Ilina AR. Peptide regulation of gene expression: systematic review. Molecules. 2021. DOI: 10.3390/molecules26227053.
6. Khavinson VK, Linkova NS, Tarnovskaya SI. Short peptides and gene expression research. Bulletin of Experimental Biology and Medicine. 2016. PMID: 27909961.
7. Ilina A, Linkova N, Petukhov M, Khavinson V. Ultrashort peptide epigenetic mechanism review. International Journal of Molecular Sciences. 2022. DOI: 10.3390/ijms23084255.
8. Allshire RC, Madhani HD. Ten principles of heterochromatin formation and function. Nature Reviews Molecular Cell Biology. 2017. DOI: 10.1038/nrm.2017.119.
9. NCBI Bookshelf. Chromosomes and chromatin. The Cell: A Molecular Approach. NCBI.
10. Luger K, Dechassa ML, Tremethick DJ. New insights into nucleosome and chromatin structure. Nature Reviews Molecular Cell Biology. 2012. DOI: 10.1038/nrm3382.
11. National Cancer Institute. Prostate definition. NCI Dictionary of Cancer Terms.
12. NCBI Bookshelf. Cellular organization of the normal prostate. Holland-Frei Cancer Medicine. NCBI.
13. Li H, et al. Prostate epithelial and stromal co-culture model. Scientific Reports. 2023.
14. International Council for Harmonisation. Q2(R2) Validation of Analytical Procedures. ICH Guideline. 2023.
15. U.S. Food and Drug Administration. Analytical procedures and methods validation guidance. FDA Guidance for Industry. 2015.
16. Mant CT, Chen Y, Hodges RS. HPLC analysis and purification of peptides. Methods in Molecular Biology. 2007.
17. Lian Z, et al. LC-MS workflow for synthetic peptide characterization. Journal of the American Society for Mass Spectrometry. 2021. PMID: 34110145.
18. Mouchahoir T, Schiel JE. LC-MS peptide mapping workflow. Analytical and Bioanalytical Chemistry. 2018.
19. National Institute of Standards and Technology. SRM definitions. NIST.
20. National Institute of Standards and Technology. Reference materials overview. NIST.
21. International Organization for Standardization. ISO/IEC 17025 testing and calibration laboratories. ISO.
22. U.S. Food and Drug Administration. Research-use-only and investigational-use-only labeling guidance. FDA Guidance. 2013.
23. Electronic Code of Federal Regulations. 21 CFR 809.10 labeling for in vitro diagnostic products. eCFR.
24. Tran D, Tran N, et al. Comparative study of peptide storage conditions. PLoS ONE. 2012.
25. Hoofnagle AN, et al. Recommendations for peptide generation, quantification, storage, and reporting. Clinical Chemistry. 2016.
26. Stawikowski M, Fields GB. Introduction to peptide synthesis. Current Protocols in Protein Science. 2002.
27. Borovskaya TG, Pakhomova AV, Vychuzhanina AV, et al. Prostamax condition-model research report. Modern Research in Inflammation. 2013. DOI: 10.4236/mri.2013.23007.
28. National Institute of Standards and Technology. Certified Reference Material definition. NIST Forensic Toxicology Lexicon. 2025.

---

Research Disclaimer

This material is supplied strictly for in vitro laboratory research and is not for human or veterinary use. Published studies describe specific experimental materials, models, and methods; they do not establish the safety, efficacy, or suitability of this catalog product for non-research use. Review the original publications and the lot-specific analytical documentation independently.